Global Immunity Nutraceutical Ingredient Market

Immunity Nutraceutical Ingredient Comprehensive Study by Type (Phytochemical and plant extracts, Omega-3 fatty acids, Minerals, Fibers & specialty carbohydrates, Carotenoids, Other Types), Application (Personal care, Functional food, Functional beverages, Dietary supplements, Animal nutrition), Product Form (Capsules, Liquids, Tablets, Powder & Granules, Others), Type (Proteins & Peptides, Vitamins & Minerals, Herbals (Ayurveda Extracts, Plant Extracts), Others (Fatty Acids and Fiber)), Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Drug Stores, Health & Beauty Stores, Online Stores), End User (Men, Women) Players and Region - Global Market Outlook to 2026

Immunity Nutraceutical Ingredient Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Immunity Nutraceutical IngredientMarket?
Immunity Nutraceutical Ingredient is known as immunity food or fortified ingredients. Nutraceutical is a combination of two words i.e. nutrient (nourishing food component) and pharmaceutical (medical drug). Nutraceuticals are the term used to describe a product which is derived from food sources with additional health benefits. It has been observed that the demand for immunity nutraceutical ingredient is increasing due to health benefits associated with it and rising health awareness across the globe. Additionally, increasing disposable income and changing lifestyle is acting as a key driver for the market. However, the cost associated with the production of immunity nutraceutical ingredient, limited production and high cost of the supplements are the factors for limiting the growth of the market. Moreover, the increasing underweight population in Asian and European countries and continuously investment for the development of products by key players can create a big opportunity for the market in the forecasted year.

Market Drivers
Increasing Demand for Immunity Nutraceutical Ingredient due to Health Benefits Associated with it, Rising Health Awareness across the globe and Increasing Demand for Fortified Food Owing to the Rising Health Consciousness

Opportunities
Increasing Underweight Population in Asian and European Countries

The Players Covered in the Study are:
Tate & Lyle PLC (United Kingdom), Koninklijke DSM N.V. (DSM) (Netherlands), Ingredion Incorporated (United States), Arla Foods (Denmark), Ajinomoto Co., Inc. (Japan), Nutraceutical Ingredients (India) and Lactonova (India)
Regulatory Framework:
There are various regulation of diet supplements. For instance, according to The Food and Drug Administration (FDA), 1. According to Nutrition Labeling and Education Act made in 1990, every diet supplement product must have bear nutrition labeling and 2. According to Dietary Supplement Health and Education Act in 1994, every diet supplement product must have specific labelling requirements and provide optional labeling stateme



Report Objectives / Segmentation Covered

By Type
  • Phytochemical and plant extracts
  • Omega-3 fatty acids
  • Minerals
  • Fibers & specialty carbohydrates
  • Carotenoids
  • Other Types
By Application
  • Personal care
  • Functional food
  • Functional beverages
  • Dietary supplements
  • Animal nutrition
By Product Form
  • Capsules
  • Liquids
  • Tablets
  • Powder & Granules
  • Others

By Type
  • Proteins & Peptides
  • Vitamins & Minerals
  • Herbals (Ayurveda Extracts, Plant Extracts)
  • Others (Fatty Acids and Fiber)

By Distribution Channel
  • Supermarkets and Hypermarkets
  • Convenience Stores
  • Drug Stores
  • Health & Beauty Stores
  • Online Stores

By End User
  • Men
  • Women

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Immunity Nutraceutical Ingredient due to Health Benefits Associated with it
      • 3.2.2. Rising Health Awareness across the globe
      • 3.2.3. Increasing Demand for Fortified Food Owing to the Rising Health Consciousness
    • 3.3. Market Challenges
      • 3.3.1. Limited Production and High Cost of the Product
    • 3.4. Market Trends
      • 3.4.1. Rising Trend for Body Fitness Boosting the Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Immunity Nutraceutical Ingredient, by Type, Application, Product Form, Type, Distribution Channel, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Immunity Nutraceutical Ingredient (Value)
      • 5.2.1. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 5.2.1.1. Phytochemical and plant extracts
        • 5.2.1.2. Omega-3 fatty acids
        • 5.2.1.3. Minerals
        • 5.2.1.4. Fibers & specialty carbohydrates
        • 5.2.1.5. Carotenoids
        • 5.2.1.6. Other Types
      • 5.2.2. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 5.2.2.1. Proteins & Peptides
        • 5.2.2.2. Vitamins & Minerals
        • 5.2.2.3. Herbals (Ayurveda Extracts, Plant Extracts)
        • 5.2.2.4. Others (Fatty Acids and Fiber)
      • 5.2.3. Global Immunity Nutraceutical Ingredient by: Application (Value)
        • 5.2.3.1. Personal care
        • 5.2.3.2. Functional food
        • 5.2.3.3. Functional beverages
        • 5.2.3.4. Dietary supplements
        • 5.2.3.5. Animal nutrition
      • 5.2.4. Global Immunity Nutraceutical Ingredient by: Product Form (Value)
        • 5.2.4.1. Capsules
        • 5.2.4.2. Liquids
        • 5.2.4.3. Tablets
        • 5.2.4.4. Powder & Granules
        • 5.2.4.5. Others
      • 5.2.5. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 5.2.5.1. Phytochemical and plant extracts
        • 5.2.5.2. Omega-3 fatty acids
        • 5.2.5.3. Minerals
        • 5.2.5.4. Fibers & specialty carbohydrates
        • 5.2.5.5. Carotenoids
        • 5.2.5.6. Other Types
      • 5.2.6. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 5.2.6.1. Proteins & Peptides
        • 5.2.6.2. Vitamins & Minerals
        • 5.2.6.3. Herbals (Ayurveda Extracts, Plant Extracts)
        • 5.2.6.4. Others (Fatty Acids and Fiber)
      • 5.2.7. Global Immunity Nutraceutical Ingredient by: Distribution Channel (Value)
        • 5.2.7.1. Supermarkets and Hypermarkets
        • 5.2.7.2. Convenience Stores
        • 5.2.7.3. Drug Stores
        • 5.2.7.4. Health & Beauty Stores
        • 5.2.7.5. Online Stores
      • 5.2.8. Global Immunity Nutraceutical Ingredient by: End User (Value)
        • 5.2.8.1. Men
        • 5.2.8.2. Women
      • 5.2.9. Global Immunity Nutraceutical Ingredient Region
        • 5.2.9.1. South America
          • 5.2.9.1.1. Brazil
          • 5.2.9.1.2. Argentina
          • 5.2.9.1.3. Rest of South America
        • 5.2.9.2. Asia Pacific
          • 5.2.9.2.1. China
          • 5.2.9.2.2. Japan
          • 5.2.9.2.3. India
          • 5.2.9.2.4. South Korea
          • 5.2.9.2.5. Taiwan
          • 5.2.9.2.6. Australia
          • 5.2.9.2.7. Rest of Asia-Pacific
        • 5.2.9.3. Europe
          • 5.2.9.3.1. Germany
          • 5.2.9.3.2. France
          • 5.2.9.3.3. Italy
          • 5.2.9.3.4. United Kingdom
          • 5.2.9.3.5. Netherlands
          • 5.2.9.3.6. Rest of Europe
        • 5.2.9.4. MEA
          • 5.2.9.4.1. Middle East
          • 5.2.9.4.2. Africa
        • 5.2.9.5. North America
          • 5.2.9.5.1. United States
          • 5.2.9.5.2. Canada
          • 5.2.9.5.3. Mexico
    • 5.3. Global Immunity Nutraceutical Ingredient (Volume)
      • 5.3.1. Global Immunity Nutraceutical Ingredient by: Type (Volume)
        • 5.3.1.1. Phytochemical and plant extracts
        • 5.3.1.2. Omega-3 fatty acids
        • 5.3.1.3. Minerals
        • 5.3.1.4. Fibers & specialty carbohydrates
        • 5.3.1.5. Carotenoids
        • 5.3.1.6. Other Types
      • 5.3.2. Global Immunity Nutraceutical Ingredient by: Type (Volume)
        • 5.3.2.1. Proteins & Peptides
        • 5.3.2.2. Vitamins & Minerals
        • 5.3.2.3. Herbals (Ayurveda Extracts, Plant Extracts)
        • 5.3.2.4. Others (Fatty Acids and Fiber)
      • 5.3.3. Global Immunity Nutraceutical Ingredient by: Application (Volume)
        • 5.3.3.1. Personal care
        • 5.3.3.2. Functional food
        • 5.3.3.3. Functional beverages
        • 5.3.3.4. Dietary supplements
        • 5.3.3.5. Animal nutrition
      • 5.3.4. Global Immunity Nutraceutical Ingredient by: Product Form (Volume)
        • 5.3.4.1. Capsules
        • 5.3.4.2. Liquids
        • 5.3.4.3. Tablets
        • 5.3.4.4. Powder & Granules
        • 5.3.4.5. Others
      • 5.3.5. Global Immunity Nutraceutical Ingredient by: Type (Volume)
        • 5.3.5.1. Phytochemical and plant extracts
        • 5.3.5.2. Omega-3 fatty acids
        • 5.3.5.3. Minerals
        • 5.3.5.4. Fibers & specialty carbohydrates
        • 5.3.5.5. Carotenoids
        • 5.3.5.6. Other Types
      • 5.3.6. Global Immunity Nutraceutical Ingredient by: Type (Volume)
        • 5.3.6.1. Proteins & Peptides
        • 5.3.6.2. Vitamins & Minerals
        • 5.3.6.3. Herbals (Ayurveda Extracts, Plant Extracts)
        • 5.3.6.4. Others (Fatty Acids and Fiber)
      • 5.3.7. Global Immunity Nutraceutical Ingredient by: Distribution Channel (Volume)
        • 5.3.7.1. Supermarkets and Hypermarkets
        • 5.3.7.2. Convenience Stores
        • 5.3.7.3. Drug Stores
        • 5.3.7.4. Health & Beauty Stores
        • 5.3.7.5. Online Stores
      • 5.3.8. Global Immunity Nutraceutical Ingredient by: End User (Volume)
        • 5.3.8.1. Men
        • 5.3.8.2. Women
      • 5.3.9. Global Immunity Nutraceutical Ingredient Region
        • 5.3.9.1. South America
          • 5.3.9.1.1. Brazil
          • 5.3.9.1.2. Argentina
          • 5.3.9.1.3. Rest of South America
        • 5.3.9.2. Asia Pacific
          • 5.3.9.2.1. China
          • 5.3.9.2.2. Japan
          • 5.3.9.2.3. India
          • 5.3.9.2.4. South Korea
          • 5.3.9.2.5. Taiwan
          • 5.3.9.2.6. Australia
          • 5.3.9.2.7. Rest of Asia-Pacific
        • 5.3.9.3. Europe
          • 5.3.9.3.1. Germany
          • 5.3.9.3.2. France
          • 5.3.9.3.3. Italy
          • 5.3.9.3.4. United Kingdom
          • 5.3.9.3.5. Netherlands
          • 5.3.9.3.6. Rest of Europe
        • 5.3.9.4. MEA
          • 5.3.9.4.1. Middle East
          • 5.3.9.4.2. Africa
        • 5.3.9.5. North America
          • 5.3.9.5.1. United States
          • 5.3.9.5.2. Canada
          • 5.3.9.5.3. Mexico
    • 5.4. Global Immunity Nutraceutical Ingredient (Price)
      • 5.4.1. Global Immunity Nutraceutical Ingredient by: Type (Price)
  • 6. Immunity Nutraceutical Ingredient: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Tate & Lyle PLC (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Koninklijke DSM N.V. (DSM) (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ingredion Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Arla Foods (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ajinomoto Co., Inc. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nutraceutical Ingredients (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lactonova (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Immunity Nutraceutical Ingredient Sale, by Type, Application, Product Form, Type, Distribution Channel, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Immunity Nutraceutical Ingredient (Value)
      • 7.2.1. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 7.2.1.1. Phytochemical and plant extracts
        • 7.2.1.2. Omega-3 fatty acids
        • 7.2.1.3. Minerals
        • 7.2.1.4. Fibers & specialty carbohydrates
        • 7.2.1.5. Carotenoids
        • 7.2.1.6. Other Types
      • 7.2.2. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 7.2.2.1. Proteins & Peptides
        • 7.2.2.2. Vitamins & Minerals
        • 7.2.2.3. Herbals (Ayurveda Extracts, Plant Extracts)
        • 7.2.2.4. Others (Fatty Acids and Fiber)
      • 7.2.3. Global Immunity Nutraceutical Ingredient by: Application (Value)
        • 7.2.3.1. Personal care
        • 7.2.3.2. Functional food
        • 7.2.3.3. Functional beverages
        • 7.2.3.4. Dietary supplements
        • 7.2.3.5. Animal nutrition
      • 7.2.4. Global Immunity Nutraceutical Ingredient by: Product Form (Value)
        • 7.2.4.1. Capsules
        • 7.2.4.2. Liquids
        • 7.2.4.3. Tablets
        • 7.2.4.4. Powder & Granules
        • 7.2.4.5. Others
      • 7.2.5. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 7.2.5.1. Phytochemical and plant extracts
        • 7.2.5.2. Omega-3 fatty acids
        • 7.2.5.3. Minerals
        • 7.2.5.4. Fibers & specialty carbohydrates
        • 7.2.5.5. Carotenoids
        • 7.2.5.6. Other Types
      • 7.2.6. Global Immunity Nutraceutical Ingredient by: Type (Value)
        • 7.2.6.1. Proteins & Peptides
        • 7.2.6.2. Vitamins & Minerals
        • 7.2.6.3. Herbals (Ayurveda Extracts, Plant Extracts)
        • 7.2.6.4. Others (Fatty Acids and Fiber)
      • 7.2.7. Global Immunity Nutraceutical Ingredient by: Distribution Channel (Value)
        • 7.2.7.1. Supermarkets and Hypermarkets
        • 7.2.7.2. Convenience Stores
        • 7.2.7.3. Drug Stores
        • 7.2.7.4. Health & Beauty Stores
        • 7.2.7.5. Online Stores
      • 7.2.8. Global Immunity Nutraceutical Ingredient by: End User (Value)
        • 7.2.8.1. Men
        • 7.2.8.2. Women
      • 7.2.9. Global Immunity Nutraceutical Ingredient Region
        • 7.2.9.1. South America
          • 7.2.9.1.1. Brazil
          • 7.2.9.1.2. Argentina
          • 7.2.9.1.3. Rest of South America
        • 7.2.9.2. Asia Pacific
          • 7.2.9.2.1. China
          • 7.2.9.2.2. Japan
          • 7.2.9.2.3. India
          • 7.2.9.2.4. South Korea
          • 7.2.9.2.5. Taiwan
          • 7.2.9.2.6. Australia
          • 7.2.9.2.7. Rest of Asia-Pacific
        • 7.2.9.3. Europe
          • 7.2.9.3.1. Germany
          • 7.2.9.3.2. France
          • 7.2.9.3.3. Italy
          • 7.2.9.3.4. United Kingdom
          • 7.2.9.3.5. Netherlands
          • 7.2.9.3.6. Rest of Europe
        • 7.2.9.4. MEA
          • 7.2.9.4.1. Middle East
          • 7.2.9.4.2. Africa
        • 7.2.9.5. North America
          • 7.2.9.5.1. United States
          • 7.2.9.5.2. Canada
          • 7.2.9.5.3. Mexico
    • 7.3. Global Immunity Nutraceutical Ingredient (Volume)
      • 7.3.1. Global Immunity Nutraceutical Ingredient by: Type (Volume)
        • 7.3.1.1. Phytochemical and plant extracts
        • 7.3.1.2. Omega-3 fatty acids
        • 7.3.1.3. Minerals
        • 7.3.1.4. Fibers & specialty carbohydrates
        • 7.3.1.5. Carotenoids
        • 7.3.1.6. Other Types
      • 7.3.2. Global Immunity Nutraceutical Ingredient by: Type (Volume)
        • 7.3.2.1. Proteins & Peptides
        • 7.3.2.2. Vitamins & Minerals
        • 7.3.2.3. Herbals (Ayurveda Extracts, Plant Extracts)
        • 7.3.2.4. Others (Fatty Acids and Fiber)
      • 7.3.3. Global Immunity Nutraceutical Ingredient by: Application (Volume)
        • 7.3.3.1. Personal care
        • 7.3.3.2. Functional food
        • 7.3.3.3. Functional beverages
        • 7.3.3.4. Dietary supplements
        • 7.3.3.5. Animal nutrition
      • 7.3.4. Global Immunity Nutraceutical Ingredient by: Product Form (Volume)
        • 7.3.4.1. Capsules
        • 7.3.4.2. Liquids
        • 7.3.4.3. Tablets
        • 7.3.4.4. Powder & Granules
        • 7.3.4.5. Others
      • 7.3.5. Global Immunity Nutraceutical Ingredient by: Type (Volume)
        • 7.3.5.1. Phytochemical and plant extracts
        • 7.3.5.2. Omega-3 fatty acids
        • 7.3.5.3. Minerals
        • 7.3.5.4. Fibers & specialty carbohydrates
        • 7.3.5.5. Carotenoids
        • 7.3.5.6. Other Types
      • 7.3.6. Global Immunity Nutraceutical Ingredient by: Type (Volume)
        • 7.3.6.1. Proteins & Peptides
        • 7.3.6.2. Vitamins & Minerals
        • 7.3.6.3. Herbals (Ayurveda Extracts, Plant Extracts)
        • 7.3.6.4. Others (Fatty Acids and Fiber)
      • 7.3.7. Global Immunity Nutraceutical Ingredient by: Distribution Channel (Volume)
        • 7.3.7.1. Supermarkets and Hypermarkets
        • 7.3.7.2. Convenience Stores
        • 7.3.7.3. Drug Stores
        • 7.3.7.4. Health & Beauty Stores
        • 7.3.7.5. Online Stores
      • 7.3.8. Global Immunity Nutraceutical Ingredient by: End User (Volume)
        • 7.3.8.1. Men
        • 7.3.8.2. Women
      • 7.3.9. Global Immunity Nutraceutical Ingredient Region
        • 7.3.9.1. South America
          • 7.3.9.1.1. Brazil
          • 7.3.9.1.2. Argentina
          • 7.3.9.1.3. Rest of South America
        • 7.3.9.2. Asia Pacific
          • 7.3.9.2.1. China
          • 7.3.9.2.2. Japan
          • 7.3.9.2.3. India
          • 7.3.9.2.4. South Korea
          • 7.3.9.2.5. Taiwan
          • 7.3.9.2.6. Australia
          • 7.3.9.2.7. Rest of Asia-Pacific
        • 7.3.9.3. Europe
          • 7.3.9.3.1. Germany
          • 7.3.9.3.2. France
          • 7.3.9.3.3. Italy
          • 7.3.9.3.4. United Kingdom
          • 7.3.9.3.5. Netherlands
          • 7.3.9.3.6. Rest of Europe
        • 7.3.9.4. MEA
          • 7.3.9.4.1. Middle East
          • 7.3.9.4.2. Africa
        • 7.3.9.5. North America
          • 7.3.9.5.1. United States
          • 7.3.9.5.2. Canada
          • 7.3.9.5.3. Mexico
    • 7.4. Global Immunity Nutraceutical Ingredient (Price)
      • 7.4.1. Global Immunity Nutraceutical Ingredient by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 2. Immunity Nutraceutical Ingredient Phytochemical and plant extracts , by Region USD Million (2015-2020)
  • Table 3. Immunity Nutraceutical Ingredient Omega-3 fatty acids , by Region USD Million (2015-2020)
  • Table 4. Immunity Nutraceutical Ingredient Minerals , by Region USD Million (2015-2020)
  • Table 5. Immunity Nutraceutical Ingredient Fibers & specialty carbohydrates , by Region USD Million (2015-2020)
  • Table 6. Immunity Nutraceutical Ingredient Carotenoids , by Region USD Million (2015-2020)
  • Table 7. Immunity Nutraceutical Ingredient Other Types , by Region USD Million (2015-2020)
  • Table 8. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 9. Immunity Nutraceutical Ingredient Proteins & Peptides , by Region USD Million (2015-2020)
  • Table 10. Immunity Nutraceutical Ingredient Vitamins & Minerals , by Region USD Million (2015-2020)
  • Table 11. Immunity Nutraceutical Ingredient Herbals (Ayurveda Extracts, Plant Extracts) , by Region USD Million (2015-2020)
  • Table 12. Immunity Nutraceutical Ingredient Others (Fatty Acids and Fiber) , by Region USD Million (2015-2020)
  • Table 13. Immunity Nutraceutical Ingredient: by Application(USD Million)
  • Table 14. Immunity Nutraceutical Ingredient Personal care , by Region USD Million (2015-2020)
  • Table 15. Immunity Nutraceutical Ingredient Functional food , by Region USD Million (2015-2020)
  • Table 16. Immunity Nutraceutical Ingredient Functional beverages , by Region USD Million (2015-2020)
  • Table 17. Immunity Nutraceutical Ingredient Dietary supplements , by Region USD Million (2015-2020)
  • Table 18. Immunity Nutraceutical Ingredient Animal nutrition , by Region USD Million (2015-2020)
  • Table 19. Immunity Nutraceutical Ingredient: by Product Form(USD Million)
  • Table 20. Immunity Nutraceutical Ingredient Capsules , by Region USD Million (2015-2020)
  • Table 21. Immunity Nutraceutical Ingredient Liquids , by Region USD Million (2015-2020)
  • Table 22. Immunity Nutraceutical Ingredient Tablets , by Region USD Million (2015-2020)
  • Table 23. Immunity Nutraceutical Ingredient Powder & Granules , by Region USD Million (2015-2020)
  • Table 24. Immunity Nutraceutical Ingredient Others , by Region USD Million (2015-2020)
  • Table 25. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 26. Immunity Nutraceutical Ingredient Phytochemical and plant extracts , by Region USD Million (2015-2020)
  • Table 27. Immunity Nutraceutical Ingredient Omega-3 fatty acids , by Region USD Million (2015-2020)
  • Table 28. Immunity Nutraceutical Ingredient Minerals , by Region USD Million (2015-2020)
  • Table 29. Immunity Nutraceutical Ingredient Fibers & specialty carbohydrates , by Region USD Million (2015-2020)
  • Table 30. Immunity Nutraceutical Ingredient Carotenoids , by Region USD Million (2015-2020)
  • Table 31. Immunity Nutraceutical Ingredient Other Types , by Region USD Million (2015-2020)
  • Table 32. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 33. Immunity Nutraceutical Ingredient Proteins & Peptides , by Region USD Million (2015-2020)
  • Table 34. Immunity Nutraceutical Ingredient Vitamins & Minerals , by Region USD Million (2015-2020)
  • Table 35. Immunity Nutraceutical Ingredient Herbals (Ayurveda Extracts, Plant Extracts) , by Region USD Million (2015-2020)
  • Table 36. Immunity Nutraceutical Ingredient Others (Fatty Acids and Fiber) , by Region USD Million (2015-2020)
  • Table 37. Immunity Nutraceutical Ingredient: by Distribution Channel(USD Million)
  • Table 38. Immunity Nutraceutical Ingredient Supermarkets and Hypermarkets , by Region USD Million (2015-2020)
  • Table 39. Immunity Nutraceutical Ingredient Convenience Stores , by Region USD Million (2015-2020)
  • Table 40. Immunity Nutraceutical Ingredient Drug Stores , by Region USD Million (2015-2020)
  • Table 41. Immunity Nutraceutical Ingredient Health & Beauty Stores , by Region USD Million (2015-2020)
  • Table 42. Immunity Nutraceutical Ingredient Online Stores , by Region USD Million (2015-2020)
  • Table 43. Immunity Nutraceutical Ingredient: by End User(USD Million)
  • Table 44. Immunity Nutraceutical Ingredient Men , by Region USD Million (2015-2020)
  • Table 45. Immunity Nutraceutical Ingredient Women , by Region USD Million (2015-2020)
  • Table 46. South America Immunity Nutraceutical Ingredient, by Country USD Million (2015-2020)
  • Table 47. South America Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 48. South America Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 49. South America Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 50. South America Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 51. South America Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 52. South America Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 53. Brazil Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 54. Brazil Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 55. Brazil Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 56. Brazil Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 57. Brazil Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 58. Brazil Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 59. Argentina Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 60. Argentina Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 61. Argentina Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 62. Argentina Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 63. Argentina Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 64. Argentina Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 65. Rest of South America Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 66. Rest of South America Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 67. Rest of South America Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 68. Rest of South America Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 69. Rest of South America Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 70. Rest of South America Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 71. Asia Pacific Immunity Nutraceutical Ingredient, by Country USD Million (2015-2020)
  • Table 72. Asia Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 73. Asia Pacific Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 74. Asia Pacific Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 75. Asia Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 76. Asia Pacific Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 77. Asia Pacific Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 78. China Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 79. China Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 80. China Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 81. China Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 82. China Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 83. China Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 84. Japan Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 85. Japan Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 86. Japan Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 87. Japan Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 88. Japan Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 89. Japan Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 90. India Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 91. India Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 92. India Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 93. India Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 94. India Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 95. India Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 96. South Korea Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 97. South Korea Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 98. South Korea Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 99. South Korea Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 100. South Korea Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 101. South Korea Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 102. Taiwan Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 103. Taiwan Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 104. Taiwan Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 105. Taiwan Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 106. Taiwan Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 107. Taiwan Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 108. Australia Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 109. Australia Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 110. Australia Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 111. Australia Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 112. Australia Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 113. Australia Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 114. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 115. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 116. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 117. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 118. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 119. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 120. Europe Immunity Nutraceutical Ingredient, by Country USD Million (2015-2020)
  • Table 121. Europe Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 122. Europe Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 123. Europe Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 124. Europe Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 125. Europe Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 126. Europe Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 127. Germany Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 128. Germany Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 129. Germany Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 130. Germany Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 131. Germany Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 132. Germany Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 133. France Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 134. France Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 135. France Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 136. France Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 137. France Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 138. France Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 139. Italy Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 140. Italy Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 141. Italy Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 142. Italy Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 143. Italy Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 144. Italy Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 145. United Kingdom Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 146. United Kingdom Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 147. United Kingdom Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 148. United Kingdom Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 149. United Kingdom Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 150. United Kingdom Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 151. Netherlands Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 152. Netherlands Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 153. Netherlands Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 154. Netherlands Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 155. Netherlands Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 156. Netherlands Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 157. Rest of Europe Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 158. Rest of Europe Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 159. Rest of Europe Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 160. Rest of Europe Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 161. Rest of Europe Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 162. Rest of Europe Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 163. MEA Immunity Nutraceutical Ingredient, by Country USD Million (2015-2020)
  • Table 164. MEA Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 165. MEA Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 166. MEA Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 167. MEA Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 168. MEA Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 169. MEA Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 170. Middle East Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 171. Middle East Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 172. Middle East Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 173. Middle East Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 174. Middle East Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 175. Middle East Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 176. Africa Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 177. Africa Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 178. Africa Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 179. Africa Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 180. Africa Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 181. Africa Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 182. North America Immunity Nutraceutical Ingredient, by Country USD Million (2015-2020)
  • Table 183. North America Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 184. North America Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 185. North America Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 186. North America Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 187. North America Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 188. North America Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 189. United States Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 190. United States Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 191. United States Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 192. United States Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 193. United States Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 194. United States Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 195. Canada Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 196. Canada Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 197. Canada Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 198. Canada Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 199. Canada Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 200. Canada Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 201. Mexico Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 202. Mexico Immunity Nutraceutical Ingredient, by Application USD Million (2015-2020)
  • Table 203. Mexico Immunity Nutraceutical Ingredient, by Product Form USD Million (2015-2020)
  • Table 204. Mexico Immunity Nutraceutical Ingredient, by Type USD Million (2015-2020)
  • Table 205. Mexico Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2015-2020)
  • Table 206. Mexico Immunity Nutraceutical Ingredient, by End User USD Million (2015-2020)
  • Table 207. Immunity Nutraceutical Ingredient Sales: by Type(K unit)
  • Table 208. Immunity Nutraceutical Ingredient Sales Phytochemical and plant extracts , by Region K unit (2015-2020)
  • Table 209. Immunity Nutraceutical Ingredient Sales Omega-3 fatty acids , by Region K unit (2015-2020)
  • Table 210. Immunity Nutraceutical Ingredient Sales Minerals , by Region K unit (2015-2020)
  • Table 211. Immunity Nutraceutical Ingredient Sales Fibers & specialty carbohydrates , by Region K unit (2015-2020)
  • Table 212. Immunity Nutraceutical Ingredient Sales Carotenoids , by Region K unit (2015-2020)
  • Table 213. Immunity Nutraceutical Ingredient Sales Other Types , by Region K unit (2015-2020)
  • Table 214. Immunity Nutraceutical Ingredient Sales: by Type(K unit)
  • Table 215. Immunity Nutraceutical Ingredient Sales Proteins & Peptides , by Region K unit (2015-2020)
  • Table 216. Immunity Nutraceutical Ingredient Sales Vitamins & Minerals , by Region K unit (2015-2020)
  • Table 217. Immunity Nutraceutical Ingredient Sales Herbals (Ayurveda Extracts, Plant Extracts) , by Region K unit (2015-2020)
  • Table 218. Immunity Nutraceutical Ingredient Sales Others (Fatty Acids and Fiber) , by Region K unit (2015-2020)
  • Table 219. Immunity Nutraceutical Ingredient Sales: by Application(K unit)
  • Table 220. Immunity Nutraceutical Ingredient Sales Personal care , by Region K unit (2015-2020)
  • Table 221. Immunity Nutraceutical Ingredient Sales Functional food , by Region K unit (2015-2020)
  • Table 222. Immunity Nutraceutical Ingredient Sales Functional beverages , by Region K unit (2015-2020)
  • Table 223. Immunity Nutraceutical Ingredient Sales Dietary supplements , by Region K unit (2015-2020)
  • Table 224. Immunity Nutraceutical Ingredient Sales Animal nutrition , by Region K unit (2015-2020)
  • Table 225. Immunity Nutraceutical Ingredient Sales: by Product Form(K unit)
  • Table 226. Immunity Nutraceutical Ingredient Sales Capsules , by Region K unit (2015-2020)
  • Table 227. Immunity Nutraceutical Ingredient Sales Liquids , by Region K unit (2015-2020)
  • Table 228. Immunity Nutraceutical Ingredient Sales Tablets , by Region K unit (2015-2020)
  • Table 229. Immunity Nutraceutical Ingredient Sales Powder & Granules , by Region K unit (2015-2020)
  • Table 230. Immunity Nutraceutical Ingredient Sales Others , by Region K unit (2015-2020)
  • Table 231. Immunity Nutraceutical Ingredient Sales: by Type(K unit)
  • Table 232. Immunity Nutraceutical Ingredient Sales Phytochemical and plant extracts , by Region K unit (2015-2020)
  • Table 233. Immunity Nutraceutical Ingredient Sales Omega-3 fatty acids , by Region K unit (2015-2020)
  • Table 234. Immunity Nutraceutical Ingredient Sales Minerals , by Region K unit (2015-2020)
  • Table 235. Immunity Nutraceutical Ingredient Sales Fibers & specialty carbohydrates , by Region K unit (2015-2020)
  • Table 236. Immunity Nutraceutical Ingredient Sales Carotenoids , by Region K unit (2015-2020)
  • Table 237. Immunity Nutraceutical Ingredient Sales Other Types , by Region K unit (2015-2020)
  • Table 238. Immunity Nutraceutical Ingredient Sales: by Type(K unit)
  • Table 239. Immunity Nutraceutical Ingredient Sales Proteins & Peptides , by Region K unit (2015-2020)
  • Table 240. Immunity Nutraceutical Ingredient Sales Vitamins & Minerals , by Region K unit (2015-2020)
  • Table 241. Immunity Nutraceutical Ingredient Sales Herbals (Ayurveda Extracts, Plant Extracts) , by Region K unit (2015-2020)
  • Table 242. Immunity Nutraceutical Ingredient Sales Others (Fatty Acids and Fiber) , by Region K unit (2015-2020)
  • Table 243. Immunity Nutraceutical Ingredient Sales: by Distribution Channel(K unit)
  • Table 244. Immunity Nutraceutical Ingredient Sales Supermarkets and Hypermarkets , by Region K unit (2015-2020)
  • Table 245. Immunity Nutraceutical Ingredient Sales Convenience Stores , by Region K unit (2015-2020)
  • Table 246. Immunity Nutraceutical Ingredient Sales Drug Stores , by Region K unit (2015-2020)
  • Table 247. Immunity Nutraceutical Ingredient Sales Health & Beauty Stores , by Region K unit (2015-2020)
  • Table 248. Immunity Nutraceutical Ingredient Sales Online Stores , by Region K unit (2015-2020)
  • Table 249. Immunity Nutraceutical Ingredient Sales: by End User(K unit)
  • Table 250. Immunity Nutraceutical Ingredient Sales Men , by Region K unit (2015-2020)
  • Table 251. Immunity Nutraceutical Ingredient Sales Women , by Region K unit (2015-2020)
  • Table 252. South America Immunity Nutraceutical Ingredient Sales, by Country K unit (2015-2020)
  • Table 253. South America Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 254. South America Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 255. South America Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 256. South America Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 257. South America Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 258. South America Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 259. Brazil Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 260. Brazil Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 261. Brazil Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 262. Brazil Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 263. Brazil Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 264. Brazil Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 265. Argentina Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 266. Argentina Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 267. Argentina Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 268. Argentina Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 269. Argentina Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 270. Argentina Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 271. Rest of South America Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 272. Rest of South America Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 273. Rest of South America Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 274. Rest of South America Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 275. Rest of South America Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 276. Rest of South America Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 277. Asia Pacific Immunity Nutraceutical Ingredient Sales, by Country K unit (2015-2020)
  • Table 278. Asia Pacific Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 279. Asia Pacific Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 280. Asia Pacific Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 281. Asia Pacific Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 282. Asia Pacific Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 283. Asia Pacific Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 284. China Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 285. China Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 286. China Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 287. China Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 288. China Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 289. China Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 290. Japan Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 291. Japan Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 292. Japan Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 293. Japan Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 294. Japan Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 295. Japan Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 296. India Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 297. India Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 298. India Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 299. India Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 300. India Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 301. India Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 302. South Korea Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 303. South Korea Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 304. South Korea Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 305. South Korea Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 306. South Korea Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 307. South Korea Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 308. Taiwan Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 309. Taiwan Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 310. Taiwan Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 311. Taiwan Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 312. Taiwan Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 313. Taiwan Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 314. Australia Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 315. Australia Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 316. Australia Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 317. Australia Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 318. Australia Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 319. Australia Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 320. Rest of Asia-Pacific Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 321. Rest of Asia-Pacific Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 322. Rest of Asia-Pacific Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 323. Rest of Asia-Pacific Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 324. Rest of Asia-Pacific Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 325. Rest of Asia-Pacific Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 326. Europe Immunity Nutraceutical Ingredient Sales, by Country K unit (2015-2020)
  • Table 327. Europe Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 328. Europe Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 329. Europe Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 330. Europe Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 331. Europe Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 332. Europe Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 333. Germany Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 334. Germany Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 335. Germany Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 336. Germany Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 337. Germany Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 338. Germany Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 339. France Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 340. France Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 341. France Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 342. France Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 343. France Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 344. France Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 345. Italy Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 346. Italy Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 347. Italy Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 348. Italy Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 349. Italy Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 350. Italy Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 351. United Kingdom Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 352. United Kingdom Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 353. United Kingdom Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 354. United Kingdom Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 355. United Kingdom Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 356. United Kingdom Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 357. Netherlands Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 358. Netherlands Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 359. Netherlands Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 360. Netherlands Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 361. Netherlands Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 362. Netherlands Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 363. Rest of Europe Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 364. Rest of Europe Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 365. Rest of Europe Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 366. Rest of Europe Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 367. Rest of Europe Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 368. Rest of Europe Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 369. MEA Immunity Nutraceutical Ingredient Sales, by Country K unit (2015-2020)
  • Table 370. MEA Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 371. MEA Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 372. MEA Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 373. MEA Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 374. MEA Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 375. MEA Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 376. Middle East Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 377. Middle East Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 378. Middle East Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 379. Middle East Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 380. Middle East Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 381. Middle East Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 382. Africa Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 383. Africa Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 384. Africa Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 385. Africa Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 386. Africa Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 387. Africa Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 388. North America Immunity Nutraceutical Ingredient Sales, by Country K unit (2015-2020)
  • Table 389. North America Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 390. North America Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 391. North America Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 392. North America Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 393. North America Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 394. North America Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 395. United States Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 396. United States Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 397. United States Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 398. United States Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 399. United States Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 400. United States Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 401. Canada Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 402. Canada Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 403. Canada Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 404. Canada Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 405. Canada Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 406. Canada Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 407. Mexico Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 408. Mexico Immunity Nutraceutical Ingredient Sales, by Application K unit (2015-2020)
  • Table 409. Mexico Immunity Nutraceutical Ingredient Sales, by Product Form K unit (2015-2020)
  • Table 410. Mexico Immunity Nutraceutical Ingredient Sales, by Type K unit (2015-2020)
  • Table 411. Mexico Immunity Nutraceutical Ingredient Sales, by Distribution Channel K unit (2015-2020)
  • Table 412. Mexico Immunity Nutraceutical Ingredient Sales, by End User K unit (2015-2020)
  • Table 413. Immunity Nutraceutical Ingredient: by Type(USD/Units)
  • Table 414. Company Basic Information, Sales Area and Its Competitors
  • Table 415. Company Basic Information, Sales Area and Its Competitors
  • Table 416. Company Basic Information, Sales Area and Its Competitors
  • Table 417. Company Basic Information, Sales Area and Its Competitors
  • Table 418. Company Basic Information, Sales Area and Its Competitors
  • Table 419. Company Basic Information, Sales Area and Its Competitors
  • Table 420. Company Basic Information, Sales Area and Its Competitors
  • Table 421. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 422. Immunity Nutraceutical Ingredient Phytochemical and plant extracts , by Region USD Million (2021-2026)
  • Table 423. Immunity Nutraceutical Ingredient Omega-3 fatty acids , by Region USD Million (2021-2026)
  • Table 424. Immunity Nutraceutical Ingredient Minerals , by Region USD Million (2021-2026)
  • Table 425. Immunity Nutraceutical Ingredient Fibers & specialty carbohydrates , by Region USD Million (2021-2026)
  • Table 426. Immunity Nutraceutical Ingredient Carotenoids , by Region USD Million (2021-2026)
  • Table 427. Immunity Nutraceutical Ingredient Other Types , by Region USD Million (2021-2026)
  • Table 428. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 429. Immunity Nutraceutical Ingredient Proteins & Peptides , by Region USD Million (2021-2026)
  • Table 430. Immunity Nutraceutical Ingredient Vitamins & Minerals , by Region USD Million (2021-2026)
  • Table 431. Immunity Nutraceutical Ingredient Herbals (Ayurveda Extracts, Plant Extracts) , by Region USD Million (2021-2026)
  • Table 432. Immunity Nutraceutical Ingredient Others (Fatty Acids and Fiber) , by Region USD Million (2021-2026)
  • Table 433. Immunity Nutraceutical Ingredient: by Application(USD Million)
  • Table 434. Immunity Nutraceutical Ingredient Personal care , by Region USD Million (2021-2026)
  • Table 435. Immunity Nutraceutical Ingredient Functional food , by Region USD Million (2021-2026)
  • Table 436. Immunity Nutraceutical Ingredient Functional beverages , by Region USD Million (2021-2026)
  • Table 437. Immunity Nutraceutical Ingredient Dietary supplements , by Region USD Million (2021-2026)
  • Table 438. Immunity Nutraceutical Ingredient Animal nutrition , by Region USD Million (2021-2026)
  • Table 439. Immunity Nutraceutical Ingredient: by Product Form(USD Million)
  • Table 440. Immunity Nutraceutical Ingredient Capsules , by Region USD Million (2021-2026)
  • Table 441. Immunity Nutraceutical Ingredient Liquids , by Region USD Million (2021-2026)
  • Table 442. Immunity Nutraceutical Ingredient Tablets , by Region USD Million (2021-2026)
  • Table 443. Immunity Nutraceutical Ingredient Powder & Granules , by Region USD Million (2021-2026)
  • Table 444. Immunity Nutraceutical Ingredient Others , by Region USD Million (2021-2026)
  • Table 445. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 446. Immunity Nutraceutical Ingredient Phytochemical and plant extracts , by Region USD Million (2021-2026)
  • Table 447. Immunity Nutraceutical Ingredient Omega-3 fatty acids , by Region USD Million (2021-2026)
  • Table 448. Immunity Nutraceutical Ingredient Minerals , by Region USD Million (2021-2026)
  • Table 449. Immunity Nutraceutical Ingredient Fibers & specialty carbohydrates , by Region USD Million (2021-2026)
  • Table 450. Immunity Nutraceutical Ingredient Carotenoids , by Region USD Million (2021-2026)
  • Table 451. Immunity Nutraceutical Ingredient Other Types , by Region USD Million (2021-2026)
  • Table 452. Immunity Nutraceutical Ingredient: by Type(USD Million)
  • Table 453. Immunity Nutraceutical Ingredient Proteins & Peptides , by Region USD Million (2021-2026)
  • Table 454. Immunity Nutraceutical Ingredient Vitamins & Minerals , by Region USD Million (2021-2026)
  • Table 455. Immunity Nutraceutical Ingredient Herbals (Ayurveda Extracts, Plant Extracts) , by Region USD Million (2021-2026)
  • Table 456. Immunity Nutraceutical Ingredient Others (Fatty Acids and Fiber) , by Region USD Million (2021-2026)
  • Table 457. Immunity Nutraceutical Ingredient: by Distribution Channel(USD Million)
  • Table 458. Immunity Nutraceutical Ingredient Supermarkets and Hypermarkets , by Region USD Million (2021-2026)
  • Table 459. Immunity Nutraceutical Ingredient Convenience Stores , by Region USD Million (2021-2026)
  • Table 460. Immunity Nutraceutical Ingredient Drug Stores , by Region USD Million (2021-2026)
  • Table 461. Immunity Nutraceutical Ingredient Health & Beauty Stores , by Region USD Million (2021-2026)
  • Table 462. Immunity Nutraceutical Ingredient Online Stores , by Region USD Million (2021-2026)
  • Table 463. Immunity Nutraceutical Ingredient: by End User(USD Million)
  • Table 464. Immunity Nutraceutical Ingredient Men , by Region USD Million (2021-2026)
  • Table 465. Immunity Nutraceutical Ingredient Women , by Region USD Million (2021-2026)
  • Table 466. South America Immunity Nutraceutical Ingredient, by Country USD Million (2021-2026)
  • Table 467. South America Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 468. South America Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 469. South America Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 470. South America Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 471. South America Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 472. South America Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 473. Brazil Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 474. Brazil Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 475. Brazil Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 476. Brazil Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 477. Brazil Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 478. Brazil Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 479. Argentina Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 480. Argentina Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 481. Argentina Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 482. Argentina Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 483. Argentina Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 484. Argentina Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 485. Rest of South America Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 486. Rest of South America Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 487. Rest of South America Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 488. Rest of South America Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 489. Rest of South America Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 490. Rest of South America Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 491. Asia Pacific Immunity Nutraceutical Ingredient, by Country USD Million (2021-2026)
  • Table 492. Asia Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 493. Asia Pacific Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 494. Asia Pacific Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 495. Asia Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 496. Asia Pacific Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 497. Asia Pacific Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 498. China Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 499. China Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 500. China Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 501. China Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 502. China Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 503. China Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 504. Japan Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 505. Japan Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 506. Japan Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 507. Japan Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 508. Japan Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 509. Japan Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 510. India Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 511. India Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 512. India Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 513. India Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 514. India Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 515. India Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 516. South Korea Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 517. South Korea Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 518. South Korea Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 519. South Korea Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 520. South Korea Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 521. South Korea Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 522. Taiwan Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 523. Taiwan Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 524. Taiwan Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 525. Taiwan Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 526. Taiwan Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 527. Taiwan Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 528. Australia Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 529. Australia Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 530. Australia Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 531. Australia Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 532. Australia Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 533. Australia Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 534. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 535. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 536. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 537. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 538. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 539. Rest of Asia-Pacific Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 540. Europe Immunity Nutraceutical Ingredient, by Country USD Million (2021-2026)
  • Table 541. Europe Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 542. Europe Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 543. Europe Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 544. Europe Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 545. Europe Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 546. Europe Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 547. Germany Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 548. Germany Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 549. Germany Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 550. Germany Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 551. Germany Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 552. Germany Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 553. France Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 554. France Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 555. France Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 556. France Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 557. France Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 558. France Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 559. Italy Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 560. Italy Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 561. Italy Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 562. Italy Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 563. Italy Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 564. Italy Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 565. United Kingdom Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 566. United Kingdom Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 567. United Kingdom Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 568. United Kingdom Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 569. United Kingdom Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 570. United Kingdom Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 571. Netherlands Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 572. Netherlands Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 573. Netherlands Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 574. Netherlands Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 575. Netherlands Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 576. Netherlands Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 577. Rest of Europe Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 578. Rest of Europe Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 579. Rest of Europe Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 580. Rest of Europe Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 581. Rest of Europe Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 582. Rest of Europe Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 583. MEA Immunity Nutraceutical Ingredient, by Country USD Million (2021-2026)
  • Table 584. MEA Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 585. MEA Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 586. MEA Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 587. MEA Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 588. MEA Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 589. MEA Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 590. Middle East Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 591. Middle East Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 592. Middle East Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 593. Middle East Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 594. Middle East Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 595. Middle East Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 596. Africa Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 597. Africa Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 598. Africa Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 599. Africa Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 600. Africa Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 601. Africa Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 602. North America Immunity Nutraceutical Ingredient, by Country USD Million (2021-2026)
  • Table 603. North America Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 604. North America Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 605. North America Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 606. North America Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 607. North America Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 608. North America Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 609. United States Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 610. United States Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 611. United States Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 612. United States Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 613. United States Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 614. United States Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 615. Canada Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 616. Canada Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 617. Canada Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 618. Canada Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 619. Canada Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 620. Canada Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 621. Mexico Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 622. Mexico Immunity Nutraceutical Ingredient, by Application USD Million (2021-2026)
  • Table 623. Mexico Immunity Nutraceutical Ingredient, by Product Form USD Million (2021-2026)
  • Table 624. Mexico Immunity Nutraceutical Ingredient, by Type USD Million (2021-2026)
  • Table 625. Mexico Immunity Nutraceutical Ingredient, by Distribution Channel USD Million (2021-2026)
  • Table 626. Mexico Immunity Nutraceutical Ingredient, by End User USD Million (2021-2026)
  • Table 627. Immunity Nutraceutical Ingredient Sales: by Type(K unit)
  • Table 628. Immunity Nutraceutical Ingredient Sales Phytochemical and plant extracts , by Region K unit (2021-2026)
  • Table 629. Immunity Nutraceutical Ingredient Sales Omega-3 fatty acids , by Region K unit (2021-2026)
  • Table 630. Immunity Nutraceutical Ingredient Sales Minerals , by Region K unit (2021-2026)
  • Table 631. Immunity Nutraceutical Ingredient Sales Fibers & specialty carbohydrates , by Region K unit (2021-2026)
  • Table 632. Immunity Nutraceutical Ingredient Sales Carotenoids , by Region K unit (2021-2026)
  • Table 633. Immunity Nutraceutical Ingredient Sales Other Types , by Region K unit (2021-2026)
  • Table 634. Immunity Nutraceutical Ingredient Sales: by Type(K unit)
  • Table 635. Immunity Nutraceutical Ingredient Sales Proteins & Peptides , by Region K unit (2021-2026)
  • Table 636. Immunity Nutraceutical Ingredient Sales Vitamins & Minerals , by Region K unit (2021-2026)
  • Table 637. Immunity Nutraceutical Ingredient Sales Herbals (Ayurveda Extracts, Plant Extracts) , by Region K unit (2021-2026)
  • Table 638. Immunity Nutraceutical Ingredient Sales Others (Fatty Acids and Fiber) , by Region K unit (2021-2026)
  • Table 639. Immunity Nutraceutical Ingredient Sales: by Application(K unit)
  • Table 640. Immunity Nutraceutical Ingredient Sales Personal care , by Region K unit (2021-2026)
  • Table 641. Immunity Nutraceutical Ingredient Sales Functional food , by Region K unit (2021-2026)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Immunity Nutraceutical Ingredient: by Type USD Million (2015-2020)
  • Figure 5. Global Immunity Nutraceutical Ingredient: by Type USD Million (2015-2020)
  • Figure 6. Global Immunity Nutraceutical Ingredient: by Application USD Million (2015-2020)
  • Figure 7. Global Immunity Nutraceutical Ingredient: by Product Form USD Million (2015-2020)
  • Figure 8. Global Immunity Nutraceutical Ingredient: by Type USD Million (2015-2020)
  • Figure 9. Global Immunity Nutraceutical Ingredient: by Type USD Million (2015-2020)
  • Figure 10. Global Immunity Nutraceutical Ingredient: by Distribution Channel USD Million (2015-2020)
  • Figure 11. Global Immunity Nutraceutical Ingredient: by End User USD Million (2015-2020)
  • Figure 12. South America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 13. Asia Pacific Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 14. Europe Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 15. MEA Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 16. North America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 17. Global Immunity Nutraceutical Ingredient: by Type K unit (2015-2020)
  • Figure 18. Global Immunity Nutraceutical Ingredient: by Type K unit (2015-2020)
  • Figure 19. Global Immunity Nutraceutical Ingredient: by Application K unit (2015-2020)
  • Figure 20. Global Immunity Nutraceutical Ingredient: by Product Form K unit (2015-2020)
  • Figure 21. Global Immunity Nutraceutical Ingredient: by Type K unit (2015-2020)
  • Figure 22. Global Immunity Nutraceutical Ingredient: by Type K unit (2015-2020)
  • Figure 23. Global Immunity Nutraceutical Ingredient: by Distribution Channel K unit (2015-2020)
  • Figure 24. Global Immunity Nutraceutical Ingredient: by End User K unit (2015-2020)
  • Figure 25. South America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 26. Asia Pacific Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 27. Europe Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 28. MEA Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 29. North America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 30. Global Immunity Nutraceutical Ingredient: by Type USD/Units (2015-2020)
  • Figure 31. Global Immunity Nutraceutical Ingredient share by Players 2020 (%)
  • Figure 32. Global Immunity Nutraceutical Ingredient share by Players (Top 3) 2020(%)
  • Figure 33. BCG Matrix for key Companies
  • Figure 34. Tate & Lyle PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Tate & Lyle PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 36. Koninklijke DSM N.V. (DSM) (Netherlands) Revenue, Net Income and Gross profit
  • Figure 37. Koninklijke DSM N.V. (DSM) (Netherlands) Revenue: by Geography 2020
  • Figure 38. Ingredion Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 39. Ingredion Incorporated (United States) Revenue: by Geography 2020
  • Figure 40. Arla Foods (Denmark) Revenue, Net Income and Gross profit
  • Figure 41. Arla Foods (Denmark) Revenue: by Geography 2020
  • Figure 42. Ajinomoto Co., Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 43. Ajinomoto Co., Inc. (Japan) Revenue: by Geography 2020
  • Figure 44. Nutraceutical Ingredients (India) Revenue, Net Income and Gross profit
  • Figure 45. Nutraceutical Ingredients (India) Revenue: by Geography 2020
  • Figure 46. Lactonova (India) Revenue, Net Income and Gross profit
  • Figure 47. Lactonova (India) Revenue: by Geography 2020
  • Figure 48. Global Immunity Nutraceutical Ingredient: by Type USD Million (2021-2026)
  • Figure 49. Global Immunity Nutraceutical Ingredient: by Type USD Million (2021-2026)
  • Figure 50. Global Immunity Nutraceutical Ingredient: by Application USD Million (2021-2026)
  • Figure 51. Global Immunity Nutraceutical Ingredient: by Product Form USD Million (2021-2026)
  • Figure 52. Global Immunity Nutraceutical Ingredient: by Type USD Million (2021-2026)
  • Figure 53. Global Immunity Nutraceutical Ingredient: by Type USD Million (2021-2026)
  • Figure 54. Global Immunity Nutraceutical Ingredient: by Distribution Channel USD Million (2021-2026)
  • Figure 55. Global Immunity Nutraceutical Ingredient: by End User USD Million (2021-2026)
  • Figure 56. South America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 57. Asia Pacific Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 58. Europe Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 59. MEA Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 60. North America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 61. Global Immunity Nutraceutical Ingredient: by Type K unit (2021-2026)
  • Figure 62. Global Immunity Nutraceutical Ingredient: by Type K unit (2021-2026)
  • Figure 63. Global Immunity Nutraceutical Ingredient: by Application K unit (2021-2026)
  • Figure 64. Global Immunity Nutraceutical Ingredient: by Product Form K unit (2021-2026)
  • Figure 65. Global Immunity Nutraceutical Ingredient: by Type K unit (2021-2026)
  • Figure 66. Global Immunity Nutraceutical Ingredient: by Type K unit (2021-2026)
  • Figure 67. Global Immunity Nutraceutical Ingredient: by Distribution Channel K unit (2021-2026)
  • Figure 68. Global Immunity Nutraceutical Ingredient: by End User K unit (2021-2026)
  • Figure 69. South America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 70. Asia Pacific Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 71. Europe Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 72. MEA Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 73. North America Immunity Nutraceutical Ingredient Share (%), by Country
  • Figure 74. Global Immunity Nutraceutical Ingredient: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Tate & Lyle PLC (United Kingdom)
  • Koninklijke DSM N.V. (DSM) (Netherlands)
  • Ingredion Incorporated (United States)
  • Arla Foods (Denmark)
  • Ajinomoto Co., Inc. (Japan)
  • Nutraceutical Ingredients (India)
  • Lactonova (India)
Select User Access Type

Key Highlights of Report


Feb 2022 214 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Immunity Nutraceutical Ingredient Market Quantitative research analysis
Global Immunity Nutraceutical Ingredient Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Immunity Nutraceutical Ingredient market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Immunity Nutraceutical Ingredient market are Tate & Lyle PLC (United Kingdom), Koninklijke DSM N.V. (DSM) (Netherlands), Ingredion Incorporated (United States), Arla Foods (Denmark), Ajinomoto Co., Inc. (Japan), Nutraceutical Ingredients (India) and Lactonova (India), to name a few.
"Rising Trend for Body Fitness Boosting the Market" is seen as one of major influencing trends for Immunity Nutraceutical Ingredient Market during projected period 2020-2026.

Know More About Global Immunity Nutraceutical Ingredient Market Report?

Have a Query? Click Here

Other Related Reports

Arrhythmia Monitoring Devices Comprehensive Study by Application (Hospitals & Clinics, Diagnostic Centres, Ambulatory Surgical Centers, Homecare Settings), Distribution Channel (Online Stores, Offlin...
$ 3450
Aspartame Free Gum Comprehensive Study by Type (Stick Gum, Tab Gum), Polyol Type (Erythritol, Xylitol, Others), Sales Channel (Online Sales, Offline Sales) Players and Region - Global Market Outlook ...
$ 3500
Pregnancy Care Product Comprehensive Study by Type (Stretch Mark Minimizer, Breast Cream, Toning/Firming Lotion, Itching Prevention Cream, Nipple Protection Cream, Others), Distribution Channel (Hosp...
$ 3800
Dental Carpule Comprehensive Study by Distribution Channel (Online Channel, Offline Channel), End-user (Hospitals, Dental Clinics, Home Care, Others), Age Group (Children, Adults), Material (Glass, P...
$ 3500
Anticonvulsants Comprehensive Study by Type (Aromatic allylic alcohols, Barbiturates, Carbamates, Benzodiazepines (Clobazam, Clonazepam), Others), Application (Epilepsy, Fibromyalgia, Migraine, Neuro...
$ 3750
Bone Allografts Comprehensive Study by Type (Fresh or fresh-frozen bone., Freeze-dried bone allograft (FDBA), Demineralized freeze-dried bone allograft (DFDBA)), Application (Spine Fusion, Dental gra...
$ 3750